Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2000 December;42(4) > Panminerva Medica 2000 December;42(4):287-91

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

CASE REPORTS  


Panminerva Medica 2000 December;42(4):287-91

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Management strategies in resection for carcinoma of the hepatic duct confluence: how to increase the resectability rate. Our experience and literature review

Leone N., De Paolis P., Carrera M., Pellicano R., Actis G. C., Fronda G. R., Rizzetto M.

From the Department of Gastroenterology *B Surgery Molinette Hospital, Turin, Italy


PDF  


The resect­ability ­rate of ­hilar ­bile ­duct car­ci­noma is ­reported to be var­i­able and to ­inversely cor­re­late ­with the ­size of the asso­ciated ­liver resec­tion. In an ­attempt to ­reduce the ­risk of post­op­er­a­tive ­liver ­failure, the induc­tion of a hyper­trophy of rem­nant ­liver by pre­op­er­a­tive ­portal ­vein embol­iza­tion (PVE) has ­been pro­posed. We ­hereby ana­lyse the ­results and the tech­nical ­aspects of ­this pro­ce­dure ­along ­with our per­sonal expe­ri­ence.

top of page

Publication History

Cite this article as

Corresponding author e-mail